{"url_path":"/sec/roiv/8-k/2026-05-20/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001635088-26-000060-index.html","accession_number":"0001635088-26-000060","cik":"0001635088","ticker":"ROIV","issuer_name":"Roivant Sciences Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001635088-26-000060-index.html","primary_entity_key":"0001635088","primary_entity_name":"Roivant Sciences Ltd."},"word_count":329,"has_tables":true,"body_markdown":"roiv-20260520\nfalse000163508800016350882026-05-202026-05-200001635088roiv:WhollyOwnedSubsidiariesAddressNYMember2026-05-202026-05-200001635088roiv:WhollyOwnedSubsidiariesAddressSwitzerlandMember2026-05-202026-05-20\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, DC 20549\n\nFORM 8-K\n\nCURRENT REPORT\n\nPursuant to Section 13 or 15(d) of the\n\nSecurities Exchange Act of 1934\n\nDate of report (Date of earliest event reported): May 20, 2026\n\nRoivant Sciences Ltd.\n\n(Exact Name of Registrant as Specified in Charter)\n\nBermuda001-4078298-1173944\n\n(State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)\n\n7th Floor\n\n50 Broadway\n\nLondon SW1H 0DB\n\nUnited Kingdom\n\n1 Pennsylvania Plaza\n\nFloor 54\n\nNew York, NY\n10119\nUnited States1\n\nViaduktstrasse 8\n\n4051 Basel\n\nSwitzerland1\n\n(Addresses of Principal Executive Offices, and Zip Code)\n\n+44 207 400 3347\n\nRegistrant’s Telephone Number, Including Area Code\n\nNot Applicable\n\n(Former Name or Former Address, if Changed Since Last Report)\n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):\n\noWritten communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\noSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\noPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\noPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:\n\nTitle of each classTrading Symbol(s)Name of each exchange on which registered\n\nCommon Shares, $0.0000000341740141 per shareROIV\nThe Nasdaq Global Select Market\n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).\n\nEmerging growth company o\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o\n\n1 Addresses of wholly-owned subsidiaries of the Registrant."}